Global Rheumatoid Arthritis Devices Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Rheumatoid Arthritis Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Rheumatoid Arthritis Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Rheumatoid Arthritis Devices market. Rheumatoid Arthritis Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Rheumatoid Arthritis Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Rheumatoid Arthritis Devices market.
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens.the implantable joint prostheses segment accounted for the largest share of the total rheumatoid arthritis market, whereas the spinal devices segment expected to witness double-digit growth rate in the coming years.
Key Features:
The report on Rheumatoid Arthritis Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Rheumatoid Arthritis Devices market. It may include historical data, market segmentation by Type (e.g., Implantable Joint Prostheses, Spinal Devices), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Rheumatoid Arthritis Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Rheumatoid Arthritis Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Rheumatoid Arthritis Devices industry. This include advancements in Rheumatoid Arthritis Devices technology, Rheumatoid Arthritis Devices new entrants, Rheumatoid Arthritis Devices new investment, and other innovations that are shaping the future of Rheumatoid Arthritis Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Rheumatoid Arthritis Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Rheumatoid Arthritis Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Rheumatoid Arthritis Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Rheumatoid Arthritis Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Rheumatoid Arthritis Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Rheumatoid Arthritis Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Rheumatoid Arthritis Devices market.
Market Segmentation:
Rheumatoid Arthritis Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Rheumatoid Arthritis Devices market?
What factors are driving Rheumatoid Arthritis Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rheumatoid Arthritis Devices market opportunities vary by end market size?
How does Rheumatoid Arthritis Devices break out type, application?
According to our LPI (LP Information) latest study, the global Rheumatoid Arthritis Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Rheumatoid Arthritis Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Rheumatoid Arthritis Devices market. Rheumatoid Arthritis Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Rheumatoid Arthritis Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Rheumatoid Arthritis Devices market.
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens.the implantable joint prostheses segment accounted for the largest share of the total rheumatoid arthritis market, whereas the spinal devices segment expected to witness double-digit growth rate in the coming years.
Key Features:
The report on Rheumatoid Arthritis Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Rheumatoid Arthritis Devices market. It may include historical data, market segmentation by Type (e.g., Implantable Joint Prostheses, Spinal Devices), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Rheumatoid Arthritis Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Rheumatoid Arthritis Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Rheumatoid Arthritis Devices industry. This include advancements in Rheumatoid Arthritis Devices technology, Rheumatoid Arthritis Devices new entrants, Rheumatoid Arthritis Devices new investment, and other innovations that are shaping the future of Rheumatoid Arthritis Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Rheumatoid Arthritis Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Rheumatoid Arthritis Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Rheumatoid Arthritis Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Rheumatoid Arthritis Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Rheumatoid Arthritis Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Rheumatoid Arthritis Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Rheumatoid Arthritis Devices market.
Market Segmentation:
Rheumatoid Arthritis Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Implantable Joint Prostheses
- Spinal Devices
- Other
- Elderly
- Young adults
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Active Implants LLC
- Anika Therapeutics, Inc.
- Arthrex, Inc.
- Asahi Kasei Pharma Corporation
- B. Braun Melsungen AG
- CONMED Corporation
- EMulate Therapeutics, Inc. (Nativis, Inc.)
- Integra Lifesciences Corporation
- Johnson & Johnson (DePuy Synthes Inc.)
- Novartis AG
- RTI Surgical, Inc.
- Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
- Setpoint Medical Corporation
- Smith & Nephew plc (Osiris Therapeutics, Inc.)
- Stryker Corporation (OrthoSpace Ltd.)
- UCB Pharma S.A.
- Zimmer Biomet
What is the 10-year outlook for the global Rheumatoid Arthritis Devices market?
What factors are driving Rheumatoid Arthritis Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rheumatoid Arthritis Devices market opportunities vary by end market size?
How does Rheumatoid Arthritis Devices break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rheumatoid Arthritis Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Rheumatoid Arthritis Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Rheumatoid Arthritis Devices by Country/Region, 2019, 2023 & 2030
2.2 Rheumatoid Arthritis Devices Segment by Type
2.2.1 Implantable Joint Prostheses
2.2.2 Spinal Devices
2.2.3 Other
2.3 Rheumatoid Arthritis Devices Sales by Type
2.3.1 Global Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Rheumatoid Arthritis Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Rheumatoid Arthritis Devices Sale Price by Type (2019-2024)
2.4 Rheumatoid Arthritis Devices Segment by Application
2.4.1 Elderly
2.4.2 Young adults
2.5 Rheumatoid Arthritis Devices Sales by Application
2.5.1 Global Rheumatoid Arthritis Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Rheumatoid Arthritis Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Rheumatoid Arthritis Devices Sale Price by Application (2019-2024)
3 GLOBAL RHEUMATOID ARTHRITIS DEVICES BY COMPANY
3.1 Global Rheumatoid Arthritis Devices Breakdown Data by Company
3.1.1 Global Rheumatoid Arthritis Devices Annual Sales by Company (2019-2024)
3.1.2 Global Rheumatoid Arthritis Devices Sales Market Share by Company (2019-2024)
3.2 Global Rheumatoid Arthritis Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Rheumatoid Arthritis Devices Revenue by Company (2019-2024)
3.2.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Company (2019-2024)
3.3 Global Rheumatoid Arthritis Devices Sale Price by Company
3.4 Key Manufacturers Rheumatoid Arthritis Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rheumatoid Arthritis Devices Product Location Distribution
3.4.2 Players Rheumatoid Arthritis Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RHEUMATOID ARTHRITIS DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Rheumatoid Arthritis Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Rheumatoid Arthritis Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Rheumatoid Arthritis Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Rheumatoid Arthritis Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Rheumatoid Arthritis Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Rheumatoid Arthritis Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Rheumatoid Arthritis Devices Sales Growth
4.4 APAC Rheumatoid Arthritis Devices Sales Growth
4.5 Europe Rheumatoid Arthritis Devices Sales Growth
4.6 Middle East & Africa Rheumatoid Arthritis Devices Sales Growth
5 AMERICAS
5.1 Americas Rheumatoid Arthritis Devices Sales by Country
5.1.1 Americas Rheumatoid Arthritis Devices Sales by Country (2019-2024)
5.1.2 Americas Rheumatoid Arthritis Devices Revenue by Country (2019-2024)
5.2 Americas Rheumatoid Arthritis Devices Sales by Type
5.3 Americas Rheumatoid Arthritis Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rheumatoid Arthritis Devices Sales by Region
6.1.1 APAC Rheumatoid Arthritis Devices Sales by Region (2019-2024)
6.1.2 APAC Rheumatoid Arthritis Devices Revenue by Region (2019-2024)
6.2 APAC Rheumatoid Arthritis Devices Sales by Type
6.3 APAC Rheumatoid Arthritis Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rheumatoid Arthritis Devices by Country
7.1.1 Europe Rheumatoid Arthritis Devices Sales by Country (2019-2024)
7.1.2 Europe Rheumatoid Arthritis Devices Revenue by Country (2019-2024)
7.2 Europe Rheumatoid Arthritis Devices Sales by Type
7.3 Europe Rheumatoid Arthritis Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rheumatoid Arthritis Devices by Country
8.1.1 Middle East & Africa Rheumatoid Arthritis Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Rheumatoid Arthritis Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Rheumatoid Arthritis Devices Sales by Type
8.3 Middle East & Africa Rheumatoid Arthritis Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rheumatoid Arthritis Devices
10.3 Manufacturing Process Analysis of Rheumatoid Arthritis Devices
10.4 Industry Chain Structure of Rheumatoid Arthritis Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rheumatoid Arthritis Devices Distributors
11.3 Rheumatoid Arthritis Devices Customer
12 WORLD FORECAST REVIEW FOR RHEUMATOID ARTHRITIS DEVICES BY GEOGRAPHIC REGION
12.1 Global Rheumatoid Arthritis Devices Market Size Forecast by Region
12.1.1 Global Rheumatoid Arthritis Devices Forecast by Region (2025-2030)
12.1.2 Global Rheumatoid Arthritis Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rheumatoid Arthritis Devices Forecast by Type
12.7 Global Rheumatoid Arthritis Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Active Implants LLC
13.1.1 Active Implants LLC Company Information
13.1.2 Active Implants LLC Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.1.3 Active Implants LLC Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Active Implants LLC Main Business Overview
13.1.5 Active Implants LLC Latest Developments
13.2 Anika Therapeutics, Inc.
13.2.1 Anika Therapeutics, Inc. Company Information
13.2.2 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Anika Therapeutics, Inc. Main Business Overview
13.2.5 Anika Therapeutics, Inc. Latest Developments
13.3 Arthrex, Inc.
13.3.1 Arthrex, Inc. Company Information
13.3.2 Arthrex, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Arthrex, Inc. Main Business Overview
13.3.5 Arthrex, Inc. Latest Developments
13.4 Asahi Kasei Pharma Corporation
13.4.1 Asahi Kasei Pharma Corporation Company Information
13.4.2 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Asahi Kasei Pharma Corporation Main Business Overview
13.4.5 Asahi Kasei Pharma Corporation Latest Developments
13.5 B. Braun Melsungen AG
13.5.1 B. Braun Melsungen AG Company Information
13.5.2 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 B. Braun Melsungen AG Main Business Overview
13.5.5 B. Braun Melsungen AG Latest Developments
13.6 CONMED Corporation
13.6.1 CONMED Corporation Company Information
13.6.2 CONMED Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.6.3 CONMED Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CONMED Corporation Main Business Overview
13.6.5 CONMED Corporation Latest Developments
13.7 EMulate Therapeutics, Inc. (Nativis, Inc.)
13.7.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Company Information
13.7.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.7.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Main Business Overview
13.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Latest Developments
13.8 Integra Lifesciences Corporation
13.8.1 Integra Lifesciences Corporation Company Information
13.8.2 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Integra Lifesciences Corporation Main Business Overview
13.8.5 Integra Lifesciences Corporation Latest Developments
13.9 Johnson & Johnson (DePuy Synthes Inc.)
13.9.1 Johnson & Johnson (DePuy Synthes Inc.) Company Information
13.9.2 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.9.3 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Johnson & Johnson (DePuy Synthes Inc.) Main Business Overview
13.9.5 Johnson & Johnson (DePuy Synthes Inc.) Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.10.3 Novartis AG Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 RTI Surgical, Inc.
13.11.1 RTI Surgical, Inc. Company Information
13.11.2 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 RTI Surgical, Inc. Main Business Overview
13.11.5 RTI Surgical, Inc. Latest Developments
13.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
13.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Company Information
13.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Main Business Overview
13.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Latest Developments
13.13 Setpoint Medical Corporation
13.13.1 Setpoint Medical Corporation Company Information
13.13.2 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Setpoint Medical Corporation Main Business Overview
13.13.5 Setpoint Medical Corporation Latest Developments
13.14 Smith & Nephew plc (Osiris Therapeutics, Inc.)
13.14.1 Smith & Nephew plc (Osiris Therapeutics, Inc.) Company Information
13.14.2 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.14.3 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Smith & Nephew plc (Osiris Therapeutics, Inc.) Main Business Overview
13.14.5 Smith & Nephew plc (Osiris Therapeutics, Inc.) Latest Developments
13.15 Stryker Corporation (OrthoSpace Ltd.)
13.15.1 Stryker Corporation (OrthoSpace Ltd.) Company Information
13.15.2 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Stryker Corporation (OrthoSpace Ltd.) Main Business Overview
13.15.5 Stryker Corporation (OrthoSpace Ltd.) Latest Developments
13.16 UCB Pharma S.A.
13.16.1 UCB Pharma S.A. Company Information
13.16.2 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 UCB Pharma S.A. Main Business Overview
13.16.5 UCB Pharma S.A. Latest Developments
13.17 Zimmer Biomet
13.17.1 Zimmer Biomet Company Information
13.17.2 Zimmer Biomet Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Zimmer Biomet Main Business Overview
13.17.5 Zimmer Biomet Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rheumatoid Arthritis Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Rheumatoid Arthritis Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Rheumatoid Arthritis Devices by Country/Region, 2019, 2023 & 2030
2.2 Rheumatoid Arthritis Devices Segment by Type
2.2.1 Implantable Joint Prostheses
2.2.2 Spinal Devices
2.2.3 Other
2.3 Rheumatoid Arthritis Devices Sales by Type
2.3.1 Global Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Rheumatoid Arthritis Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Rheumatoid Arthritis Devices Sale Price by Type (2019-2024)
2.4 Rheumatoid Arthritis Devices Segment by Application
2.4.1 Elderly
2.4.2 Young adults
2.5 Rheumatoid Arthritis Devices Sales by Application
2.5.1 Global Rheumatoid Arthritis Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Rheumatoid Arthritis Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Rheumatoid Arthritis Devices Sale Price by Application (2019-2024)
3 GLOBAL RHEUMATOID ARTHRITIS DEVICES BY COMPANY
3.1 Global Rheumatoid Arthritis Devices Breakdown Data by Company
3.1.1 Global Rheumatoid Arthritis Devices Annual Sales by Company (2019-2024)
3.1.2 Global Rheumatoid Arthritis Devices Sales Market Share by Company (2019-2024)
3.2 Global Rheumatoid Arthritis Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Rheumatoid Arthritis Devices Revenue by Company (2019-2024)
3.2.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Company (2019-2024)
3.3 Global Rheumatoid Arthritis Devices Sale Price by Company
3.4 Key Manufacturers Rheumatoid Arthritis Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rheumatoid Arthritis Devices Product Location Distribution
3.4.2 Players Rheumatoid Arthritis Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RHEUMATOID ARTHRITIS DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Rheumatoid Arthritis Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Rheumatoid Arthritis Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Rheumatoid Arthritis Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Rheumatoid Arthritis Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Rheumatoid Arthritis Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Rheumatoid Arthritis Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Rheumatoid Arthritis Devices Sales Growth
4.4 APAC Rheumatoid Arthritis Devices Sales Growth
4.5 Europe Rheumatoid Arthritis Devices Sales Growth
4.6 Middle East & Africa Rheumatoid Arthritis Devices Sales Growth
5 AMERICAS
5.1 Americas Rheumatoid Arthritis Devices Sales by Country
5.1.1 Americas Rheumatoid Arthritis Devices Sales by Country (2019-2024)
5.1.2 Americas Rheumatoid Arthritis Devices Revenue by Country (2019-2024)
5.2 Americas Rheumatoid Arthritis Devices Sales by Type
5.3 Americas Rheumatoid Arthritis Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rheumatoid Arthritis Devices Sales by Region
6.1.1 APAC Rheumatoid Arthritis Devices Sales by Region (2019-2024)
6.1.2 APAC Rheumatoid Arthritis Devices Revenue by Region (2019-2024)
6.2 APAC Rheumatoid Arthritis Devices Sales by Type
6.3 APAC Rheumatoid Arthritis Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rheumatoid Arthritis Devices by Country
7.1.1 Europe Rheumatoid Arthritis Devices Sales by Country (2019-2024)
7.1.2 Europe Rheumatoid Arthritis Devices Revenue by Country (2019-2024)
7.2 Europe Rheumatoid Arthritis Devices Sales by Type
7.3 Europe Rheumatoid Arthritis Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rheumatoid Arthritis Devices by Country
8.1.1 Middle East & Africa Rheumatoid Arthritis Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Rheumatoid Arthritis Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Rheumatoid Arthritis Devices Sales by Type
8.3 Middle East & Africa Rheumatoid Arthritis Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rheumatoid Arthritis Devices
10.3 Manufacturing Process Analysis of Rheumatoid Arthritis Devices
10.4 Industry Chain Structure of Rheumatoid Arthritis Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rheumatoid Arthritis Devices Distributors
11.3 Rheumatoid Arthritis Devices Customer
12 WORLD FORECAST REVIEW FOR RHEUMATOID ARTHRITIS DEVICES BY GEOGRAPHIC REGION
12.1 Global Rheumatoid Arthritis Devices Market Size Forecast by Region
12.1.1 Global Rheumatoid Arthritis Devices Forecast by Region (2025-2030)
12.1.2 Global Rheumatoid Arthritis Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rheumatoid Arthritis Devices Forecast by Type
12.7 Global Rheumatoid Arthritis Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Active Implants LLC
13.1.1 Active Implants LLC Company Information
13.1.2 Active Implants LLC Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.1.3 Active Implants LLC Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Active Implants LLC Main Business Overview
13.1.5 Active Implants LLC Latest Developments
13.2 Anika Therapeutics, Inc.
13.2.1 Anika Therapeutics, Inc. Company Information
13.2.2 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Anika Therapeutics, Inc. Main Business Overview
13.2.5 Anika Therapeutics, Inc. Latest Developments
13.3 Arthrex, Inc.
13.3.1 Arthrex, Inc. Company Information
13.3.2 Arthrex, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Arthrex, Inc. Main Business Overview
13.3.5 Arthrex, Inc. Latest Developments
13.4 Asahi Kasei Pharma Corporation
13.4.1 Asahi Kasei Pharma Corporation Company Information
13.4.2 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Asahi Kasei Pharma Corporation Main Business Overview
13.4.5 Asahi Kasei Pharma Corporation Latest Developments
13.5 B. Braun Melsungen AG
13.5.1 B. Braun Melsungen AG Company Information
13.5.2 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 B. Braun Melsungen AG Main Business Overview
13.5.5 B. Braun Melsungen AG Latest Developments
13.6 CONMED Corporation
13.6.1 CONMED Corporation Company Information
13.6.2 CONMED Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.6.3 CONMED Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CONMED Corporation Main Business Overview
13.6.5 CONMED Corporation Latest Developments
13.7 EMulate Therapeutics, Inc. (Nativis, Inc.)
13.7.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Company Information
13.7.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.7.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Main Business Overview
13.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Latest Developments
13.8 Integra Lifesciences Corporation
13.8.1 Integra Lifesciences Corporation Company Information
13.8.2 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Integra Lifesciences Corporation Main Business Overview
13.8.5 Integra Lifesciences Corporation Latest Developments
13.9 Johnson & Johnson (DePuy Synthes Inc.)
13.9.1 Johnson & Johnson (DePuy Synthes Inc.) Company Information
13.9.2 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.9.3 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Johnson & Johnson (DePuy Synthes Inc.) Main Business Overview
13.9.5 Johnson & Johnson (DePuy Synthes Inc.) Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.10.3 Novartis AG Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 RTI Surgical, Inc.
13.11.1 RTI Surgical, Inc. Company Information
13.11.2 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 RTI Surgical, Inc. Main Business Overview
13.11.5 RTI Surgical, Inc. Latest Developments
13.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
13.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Company Information
13.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Main Business Overview
13.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Latest Developments
13.13 Setpoint Medical Corporation
13.13.1 Setpoint Medical Corporation Company Information
13.13.2 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Setpoint Medical Corporation Main Business Overview
13.13.5 Setpoint Medical Corporation Latest Developments
13.14 Smith & Nephew plc (Osiris Therapeutics, Inc.)
13.14.1 Smith & Nephew plc (Osiris Therapeutics, Inc.) Company Information
13.14.2 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.14.3 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Smith & Nephew plc (Osiris Therapeutics, Inc.) Main Business Overview
13.14.5 Smith & Nephew plc (Osiris Therapeutics, Inc.) Latest Developments
13.15 Stryker Corporation (OrthoSpace Ltd.)
13.15.1 Stryker Corporation (OrthoSpace Ltd.) Company Information
13.15.2 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Stryker Corporation (OrthoSpace Ltd.) Main Business Overview
13.15.5 Stryker Corporation (OrthoSpace Ltd.) Latest Developments
13.16 UCB Pharma S.A.
13.16.1 UCB Pharma S.A. Company Information
13.16.2 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 UCB Pharma S.A. Main Business Overview
13.16.5 UCB Pharma S.A. Latest Developments
13.17 Zimmer Biomet
13.17.1 Zimmer Biomet Company Information
13.17.2 Zimmer Biomet Rheumatoid Arthritis Devices Product Portfolios and Specifications
13.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Zimmer Biomet Main Business Overview
13.17.5 Zimmer Biomet Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rheumatoid Arthritis Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Rheumatoid Arthritis Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Implantable Joint Prostheses
Table 4. Major Players of Spinal Devices
Table 5. Major Players of Other
Table 6. Global Rheumatoid Arthritis Devices Sales by Type (2019-2024) & (K Units)
Table 7. Global Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Table 8. Global Rheumatoid Arthritis Devices Revenue by Type (2019-2024) & ($ million)
Table 9. Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2019-2024)
Table 10. Global Rheumatoid Arthritis Devices Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Rheumatoid Arthritis Devices Sales by Application (2019-2024) & (K Units)
Table 12. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Table 13. Global Rheumatoid Arthritis Devices Revenue by Application (2019-2024)
Table 14. Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2019-2024)
Table 15. Global Rheumatoid Arthritis Devices Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Rheumatoid Arthritis Devices Sales by Company (2019-2024) & (K Units)
Table 17. Global Rheumatoid Arthritis Devices Sales Market Share by Company (2019-2024)
Table 18. Global Rheumatoid Arthritis Devices Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Rheumatoid Arthritis Devices Revenue Market Share by Company (2019-2024)
Table 20. Global Rheumatoid Arthritis Devices Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Rheumatoid Arthritis Devices Producing Area Distribution and Sales Area
Table 22. Players Rheumatoid Arthritis Devices Products Offered
Table 23. Rheumatoid Arthritis Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Rheumatoid Arthritis Devices Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Rheumatoid Arthritis Devices Sales Market Share Geographic Region (2019-2024)
Table 28. Global Rheumatoid Arthritis Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Rheumatoid Arthritis Devices Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Rheumatoid Arthritis Devices Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Rheumatoid Arthritis Devices Sales Market Share by Country/Region (2019-2024)
Table 32. Global Rheumatoid Arthritis Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Rheumatoid Arthritis Devices Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Rheumatoid Arthritis Devices Sales by Country (2019-2024) & (K Units)
Table 35. Americas Rheumatoid Arthritis Devices Sales Market Share by Country (2019-2024)
Table 36. Americas Rheumatoid Arthritis Devices Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Rheumatoid Arthritis Devices Revenue Market Share by Country (2019-2024)
Table 38. Americas Rheumatoid Arthritis Devices Sales by Type (2019-2024) & (K Units)
Table 39. Americas Rheumatoid Arthritis Devices Sales by Application (2019-2024) & (K Units)
Table 40. APAC Rheumatoid Arthritis Devices Sales by Region (2019-2024) & (K Units)
Table 41. APAC Rheumatoid Arthritis Devices Sales Market Share by Region (2019-2024)
Table 42. APAC Rheumatoid Arthritis Devices Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Rheumatoid Arthritis Devices Revenue Market Share by Region (2019-2024)
Table 44. APAC Rheumatoid Arthritis Devices Sales by Type (2019-2024) & (K Units)
Table 45. APAC Rheumatoid Arthritis Devices Sales by Application (2019-2024) & (K Units)
Table 46. Europe Rheumatoid Arthritis Devices Sales by Country (2019-2024) & (K Units)
Table 47. Europe Rheumatoid Arthritis Devices Sales Market Share by Country (2019-2024)
Table 48. Europe Rheumatoid Arthritis Devices Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Rheumatoid Arthritis Devices Revenue Market Share by Country (2019-2024)
Table 50. Europe Rheumatoid Arthritis Devices Sales by Type (2019-2024) & (K Units)
Table 51. Europe Rheumatoid Arthritis Devices Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Rheumatoid Arthritis Devices Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Rheumatoid Arthritis Devices Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Rheumatoid Arthritis Devices Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Rheumatoid Arthritis Devices Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Rheumatoid Arthritis Devices Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Rheumatoid Arthritis Devices
Table 59. Key Market Challenges & Risks of Rheumatoid Arthritis Devices
Table 60. Key Industry Trends of Rheumatoid Arthritis Devices
Table 61. Rheumatoid Arthritis Devices Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Rheumatoid Arthritis Devices Distributors List
Table 64. Rheumatoid Arthritis Devices Customer List
Table 65. Global Rheumatoid Arthritis Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Rheumatoid Arthritis Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Rheumatoid Arthritis Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Rheumatoid Arthritis Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Rheumatoid Arthritis Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Rheumatoid Arthritis Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Rheumatoid Arthritis Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Rheumatoid Arthritis Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Rheumatoid Arthritis Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Rheumatoid Arthritis Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Rheumatoid Arthritis Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Rheumatoid Arthritis Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Rheumatoid Arthritis Devices Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Rheumatoid Arthritis Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Active Implants LLC Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. Active Implants LLC Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 81. Active Implants LLC Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Active Implants LLC Main Business
Table 83. Active Implants LLC Latest Developments
Table 84. Anika Therapeutics, Inc. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 86. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Anika Therapeutics, Inc. Main Business
Table 88. Anika Therapeutics, Inc. Latest Developments
Table 89. Arthrex, Inc. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 90. Arthrex, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 91. Arthrex, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Arthrex, Inc. Main Business
Table 93. Arthrex, Inc. Latest Developments
Table 94. Asahi Kasei Pharma Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 96. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Asahi Kasei Pharma Corporation Main Business
Table 98. Asahi Kasei Pharma Corporation Latest Developments
Table 99. B. Braun Melsungen AG Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 101. B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. B. Braun Melsungen AG Main Business
Table 103. B. Braun Melsungen AG Latest Developments
Table 104. CONMED Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. CONMED Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 106. CONMED Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. CONMED Corporation Main Business
Table 108. CONMED Corporation Latest Developments
Table 109. EMulate Therapeutics, Inc. (Nativis, Inc.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 111. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. EMulate Therapeutics, Inc. (Nativis, Inc.) Main Business
Table 113. EMulate Therapeutics, Inc. (Nativis, Inc.) Latest Developments
Table 114. Integra Lifesciences Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 115. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 116. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Integra Lifesciences Corporation Main Business
Table 118. Integra Lifesciences Corporation Latest Developments
Table 119. Johnson & Johnson (DePuy Synthes Inc.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 120. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 121. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Johnson & Johnson (DePuy Synthes Inc.) Main Business
Table 123. Johnson & Johnson (DePuy Synthes Inc.) Latest Developments
Table 124. Novartis AG Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis AG Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 126. Novartis AG Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Novartis AG Main Business
Table 128. Novartis AG Latest Developments
Table 129. RTI Surgical, Inc. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 130. RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 131. RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. RTI Surgical, Inc. Main Business
Table 133. RTI Surgical, Inc. Latest Developments
Table 134. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 135. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 136. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Main Business
Table 138. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Latest Developments
Table 139. Setpoint Medical Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 140. Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 141. Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Setpoint Medical Corporation Main Business
Table 143. Setpoint Medical Corporation Latest Developments
Table 144. Smith & Nephew plc (Osiris Therapeutics, Inc.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 145. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 146. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Smith & Nephew plc (Osiris Therapeutics, Inc.) Main Business
Table 148. Smith & Nephew plc (Osiris Therapeutics, Inc.) Latest Developments
Table 149. Stryker Corporation (OrthoSpace Ltd.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 150. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 151. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Stryker Corporation (OrthoSpace Ltd.) Main Business
Table 153. Stryker Corporation (OrthoSpace Ltd.) Latest Developments
Table 154. UCB Pharma S.A. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 155. UCB Pharma S.A. Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 156. UCB Pharma S.A. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157. UCB Pharma S.A. Main Business
Table 158. UCB Pharma S.A. Latest Developments
Table 159. Zimmer Biomet Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 160. Zimmer Biomet Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 161. Zimmer Biomet Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 162. Zimmer Biomet Main Business
Table 163. Zimmer Biomet Latest Developments
Table 1. Rheumatoid Arthritis Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Rheumatoid Arthritis Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Implantable Joint Prostheses
Table 4. Major Players of Spinal Devices
Table 5. Major Players of Other
Table 6. Global Rheumatoid Arthritis Devices Sales by Type (2019-2024) & (K Units)
Table 7. Global Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Table 8. Global Rheumatoid Arthritis Devices Revenue by Type (2019-2024) & ($ million)
Table 9. Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2019-2024)
Table 10. Global Rheumatoid Arthritis Devices Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Rheumatoid Arthritis Devices Sales by Application (2019-2024) & (K Units)
Table 12. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Table 13. Global Rheumatoid Arthritis Devices Revenue by Application (2019-2024)
Table 14. Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2019-2024)
Table 15. Global Rheumatoid Arthritis Devices Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Rheumatoid Arthritis Devices Sales by Company (2019-2024) & (K Units)
Table 17. Global Rheumatoid Arthritis Devices Sales Market Share by Company (2019-2024)
Table 18. Global Rheumatoid Arthritis Devices Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Rheumatoid Arthritis Devices Revenue Market Share by Company (2019-2024)
Table 20. Global Rheumatoid Arthritis Devices Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Rheumatoid Arthritis Devices Producing Area Distribution and Sales Area
Table 22. Players Rheumatoid Arthritis Devices Products Offered
Table 23. Rheumatoid Arthritis Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Rheumatoid Arthritis Devices Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Rheumatoid Arthritis Devices Sales Market Share Geographic Region (2019-2024)
Table 28. Global Rheumatoid Arthritis Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Rheumatoid Arthritis Devices Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Rheumatoid Arthritis Devices Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Rheumatoid Arthritis Devices Sales Market Share by Country/Region (2019-2024)
Table 32. Global Rheumatoid Arthritis Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Rheumatoid Arthritis Devices Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Rheumatoid Arthritis Devices Sales by Country (2019-2024) & (K Units)
Table 35. Americas Rheumatoid Arthritis Devices Sales Market Share by Country (2019-2024)
Table 36. Americas Rheumatoid Arthritis Devices Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Rheumatoid Arthritis Devices Revenue Market Share by Country (2019-2024)
Table 38. Americas Rheumatoid Arthritis Devices Sales by Type (2019-2024) & (K Units)
Table 39. Americas Rheumatoid Arthritis Devices Sales by Application (2019-2024) & (K Units)
Table 40. APAC Rheumatoid Arthritis Devices Sales by Region (2019-2024) & (K Units)
Table 41. APAC Rheumatoid Arthritis Devices Sales Market Share by Region (2019-2024)
Table 42. APAC Rheumatoid Arthritis Devices Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Rheumatoid Arthritis Devices Revenue Market Share by Region (2019-2024)
Table 44. APAC Rheumatoid Arthritis Devices Sales by Type (2019-2024) & (K Units)
Table 45. APAC Rheumatoid Arthritis Devices Sales by Application (2019-2024) & (K Units)
Table 46. Europe Rheumatoid Arthritis Devices Sales by Country (2019-2024) & (K Units)
Table 47. Europe Rheumatoid Arthritis Devices Sales Market Share by Country (2019-2024)
Table 48. Europe Rheumatoid Arthritis Devices Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Rheumatoid Arthritis Devices Revenue Market Share by Country (2019-2024)
Table 50. Europe Rheumatoid Arthritis Devices Sales by Type (2019-2024) & (K Units)
Table 51. Europe Rheumatoid Arthritis Devices Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Rheumatoid Arthritis Devices Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Rheumatoid Arthritis Devices Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Rheumatoid Arthritis Devices Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Rheumatoid Arthritis Devices Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Rheumatoid Arthritis Devices Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Rheumatoid Arthritis Devices
Table 59. Key Market Challenges & Risks of Rheumatoid Arthritis Devices
Table 60. Key Industry Trends of Rheumatoid Arthritis Devices
Table 61. Rheumatoid Arthritis Devices Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Rheumatoid Arthritis Devices Distributors List
Table 64. Rheumatoid Arthritis Devices Customer List
Table 65. Global Rheumatoid Arthritis Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Rheumatoid Arthritis Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Rheumatoid Arthritis Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Rheumatoid Arthritis Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Rheumatoid Arthritis Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Rheumatoid Arthritis Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Rheumatoid Arthritis Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Rheumatoid Arthritis Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Rheumatoid Arthritis Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Rheumatoid Arthritis Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Rheumatoid Arthritis Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Rheumatoid Arthritis Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Rheumatoid Arthritis Devices Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Rheumatoid Arthritis Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Active Implants LLC Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. Active Implants LLC Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 81. Active Implants LLC Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Active Implants LLC Main Business
Table 83. Active Implants LLC Latest Developments
Table 84. Anika Therapeutics, Inc. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 86. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Anika Therapeutics, Inc. Main Business
Table 88. Anika Therapeutics, Inc. Latest Developments
Table 89. Arthrex, Inc. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 90. Arthrex, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 91. Arthrex, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Arthrex, Inc. Main Business
Table 93. Arthrex, Inc. Latest Developments
Table 94. Asahi Kasei Pharma Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 96. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Asahi Kasei Pharma Corporation Main Business
Table 98. Asahi Kasei Pharma Corporation Latest Developments
Table 99. B. Braun Melsungen AG Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 101. B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. B. Braun Melsungen AG Main Business
Table 103. B. Braun Melsungen AG Latest Developments
Table 104. CONMED Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. CONMED Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 106. CONMED Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. CONMED Corporation Main Business
Table 108. CONMED Corporation Latest Developments
Table 109. EMulate Therapeutics, Inc. (Nativis, Inc.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 111. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. EMulate Therapeutics, Inc. (Nativis, Inc.) Main Business
Table 113. EMulate Therapeutics, Inc. (Nativis, Inc.) Latest Developments
Table 114. Integra Lifesciences Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 115. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 116. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Integra Lifesciences Corporation Main Business
Table 118. Integra Lifesciences Corporation Latest Developments
Table 119. Johnson & Johnson (DePuy Synthes Inc.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 120. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 121. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Johnson & Johnson (DePuy Synthes Inc.) Main Business
Table 123. Johnson & Johnson (DePuy Synthes Inc.) Latest Developments
Table 124. Novartis AG Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis AG Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 126. Novartis AG Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Novartis AG Main Business
Table 128. Novartis AG Latest Developments
Table 129. RTI Surgical, Inc. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 130. RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 131. RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. RTI Surgical, Inc. Main Business
Table 133. RTI Surgical, Inc. Latest Developments
Table 134. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 135. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 136. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Main Business
Table 138. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Latest Developments
Table 139. Setpoint Medical Corporation Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 140. Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 141. Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Setpoint Medical Corporation Main Business
Table 143. Setpoint Medical Corporation Latest Developments
Table 144. Smith & Nephew plc (Osiris Therapeutics, Inc.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 145. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 146. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Smith & Nephew plc (Osiris Therapeutics, Inc.) Main Business
Table 148. Smith & Nephew plc (Osiris Therapeutics, Inc.) Latest Developments
Table 149. Stryker Corporation (OrthoSpace Ltd.) Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 150. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 151. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Stryker Corporation (OrthoSpace Ltd.) Main Business
Table 153. Stryker Corporation (OrthoSpace Ltd.) Latest Developments
Table 154. UCB Pharma S.A. Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 155. UCB Pharma S.A. Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 156. UCB Pharma S.A. Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157. UCB Pharma S.A. Main Business
Table 158. UCB Pharma S.A. Latest Developments
Table 159. Zimmer Biomet Basic Information, Rheumatoid Arthritis Devices Manufacturing Base, Sales Area and Its Competitors
Table 160. Zimmer Biomet Rheumatoid Arthritis Devices Product Portfolios and Specifications
Table 161. Zimmer Biomet Rheumatoid Arthritis Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 162. Zimmer Biomet Main Business
Table 163. Zimmer Biomet Latest Developments
LIST OF FIGURES
Figure 1. Picture of Rheumatoid Arthritis Devices
Figure 2. Rheumatoid Arthritis Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rheumatoid Arthritis Devices Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Rheumatoid Arthritis Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Rheumatoid Arthritis Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Implantable Joint Prostheses
Figure 10. Product Picture of Spinal Devices
Figure 11. Product Picture of Other
Figure 12. Global Rheumatoid Arthritis Devices Sales Market Share by Type in 2023
Figure 13. Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2019-2024)
Figure 14. Rheumatoid Arthritis Devices Consumed in Elderly
Figure 15. Global Rheumatoid Arthritis Devices Market: Elderly (2019-2024) & (K Units)
Figure 16. Rheumatoid Arthritis Devices Consumed in Young adults
Figure 17. Global Rheumatoid Arthritis Devices Market: Young adults (2019-2024) & (K Units)
Figure 18. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2023)
Figure 19. Global Rheumatoid Arthritis Devices Revenue Market Share by Application in 2023
Figure 20. Rheumatoid Arthritis Devices Sales Market by Company in 2023 (K Units)
Figure 21. Global Rheumatoid Arthritis Devices Sales Market Share by Company in 2023
Figure 22. Rheumatoid Arthritis Devices Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Rheumatoid Arthritis Devices Revenue Market Share by Company in 2023
Figure 24. Global Rheumatoid Arthritis Devices Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Rheumatoid Arthritis Devices Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Rheumatoid Arthritis Devices Sales 2019-2024 (K Units)
Figure 27. Americas Rheumatoid Arthritis Devices Revenue 2019-2024 ($ Millions)
Figure 28. APAC Rheumatoid Arthritis Devices Sales 2019-2024 (K Units)
Figure 29. APAC Rheumatoid Arthritis Devices Revenue 2019-2024 ($ Millions)
Figure 30. Europe Rheumatoid Arthritis Devices Sales 2019-2024 (K Units)
Figure 31. Europe Rheumatoid Arthritis Devices Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Rheumatoid Arthritis Devices Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa Rheumatoid Arthritis Devices Revenue 2019-2024 ($ Millions)
Figure 34. Americas Rheumatoid Arthritis Devices Sales Market Share by Country in 2023
Figure 35. Americas Rheumatoid Arthritis Devices Revenue Market Share by Country in 2023
Figure 36. Americas Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Figure 37. Americas Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Figure 38. United States Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Rheumatoid Arthritis Devices Sales Market Share by Region in 2023
Figure 43. APAC Rheumatoid Arthritis Devices Revenue Market Share by Regions in 2023
Figure 44. APAC Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Figure 45. APAC Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Figure 46. China Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Rheumatoid Arthritis Devices Sales Market Share by Country in 2023
Figure 54. Europe Rheumatoid Arthritis Devices Revenue Market Share by Country in 2023
Figure 55. Europe Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Figure 56. Europe Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Figure 57. Germany Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Rheumatoid Arthritis Devices Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Figure 66. Egypt Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Rheumatoid Arthritis Devices in 2023
Figure 72. Manufacturing Process Analysis of Rheumatoid Arthritis Devices
Figure 73. Industry Chain Structure of Rheumatoid Arthritis Devices
Figure 74. Channels of Distribution
Figure 75. Global Rheumatoid Arthritis Devices Sales Market Forecast by Region (2025-2030)
Figure 76. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Rheumatoid Arthritis Devices Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Rheumatoid Arthritis Devices Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Rheumatoid Arthritis Devices
Figure 2. Rheumatoid Arthritis Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rheumatoid Arthritis Devices Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Rheumatoid Arthritis Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Rheumatoid Arthritis Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Implantable Joint Prostheses
Figure 10. Product Picture of Spinal Devices
Figure 11. Product Picture of Other
Figure 12. Global Rheumatoid Arthritis Devices Sales Market Share by Type in 2023
Figure 13. Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2019-2024)
Figure 14. Rheumatoid Arthritis Devices Consumed in Elderly
Figure 15. Global Rheumatoid Arthritis Devices Market: Elderly (2019-2024) & (K Units)
Figure 16. Rheumatoid Arthritis Devices Consumed in Young adults
Figure 17. Global Rheumatoid Arthritis Devices Market: Young adults (2019-2024) & (K Units)
Figure 18. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2023)
Figure 19. Global Rheumatoid Arthritis Devices Revenue Market Share by Application in 2023
Figure 20. Rheumatoid Arthritis Devices Sales Market by Company in 2023 (K Units)
Figure 21. Global Rheumatoid Arthritis Devices Sales Market Share by Company in 2023
Figure 22. Rheumatoid Arthritis Devices Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Rheumatoid Arthritis Devices Revenue Market Share by Company in 2023
Figure 24. Global Rheumatoid Arthritis Devices Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Rheumatoid Arthritis Devices Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Rheumatoid Arthritis Devices Sales 2019-2024 (K Units)
Figure 27. Americas Rheumatoid Arthritis Devices Revenue 2019-2024 ($ Millions)
Figure 28. APAC Rheumatoid Arthritis Devices Sales 2019-2024 (K Units)
Figure 29. APAC Rheumatoid Arthritis Devices Revenue 2019-2024 ($ Millions)
Figure 30. Europe Rheumatoid Arthritis Devices Sales 2019-2024 (K Units)
Figure 31. Europe Rheumatoid Arthritis Devices Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Rheumatoid Arthritis Devices Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa Rheumatoid Arthritis Devices Revenue 2019-2024 ($ Millions)
Figure 34. Americas Rheumatoid Arthritis Devices Sales Market Share by Country in 2023
Figure 35. Americas Rheumatoid Arthritis Devices Revenue Market Share by Country in 2023
Figure 36. Americas Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Figure 37. Americas Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Figure 38. United States Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Rheumatoid Arthritis Devices Sales Market Share by Region in 2023
Figure 43. APAC Rheumatoid Arthritis Devices Revenue Market Share by Regions in 2023
Figure 44. APAC Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Figure 45. APAC Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Figure 46. China Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Rheumatoid Arthritis Devices Sales Market Share by Country in 2023
Figure 54. Europe Rheumatoid Arthritis Devices Revenue Market Share by Country in 2023
Figure 55. Europe Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Figure 56. Europe Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Figure 57. Germany Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Rheumatoid Arthritis Devices Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Rheumatoid Arthritis Devices Sales Market Share by Application (2019-2024)
Figure 66. Egypt Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Rheumatoid Arthritis Devices Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Rheumatoid Arthritis Devices in 2023
Figure 72. Manufacturing Process Analysis of Rheumatoid Arthritis Devices
Figure 73. Industry Chain Structure of Rheumatoid Arthritis Devices
Figure 74. Channels of Distribution
Figure 75. Global Rheumatoid Arthritis Devices Sales Market Forecast by Region (2025-2030)
Figure 76. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Rheumatoid Arthritis Devices Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Rheumatoid Arthritis Devices Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Application (2025-2030)
